Detalhe da pesquisa
1.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Lancet Oncol
; 13(1): 43-54, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22169269
2.
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.
Clin Transl Radiat Oncol
; 21: 77-84, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072028
3.
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
Radiother Oncol
; 142: 62-71, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767473
4.
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).
Int J Radiat Oncol Biol Phys
; 103(3): 605-617, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528653
5.
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
BMJ Open
; 8(4): e020690, 2018 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666135
6.
An analytical approach to acceptance criteria for quality assurance of Intensity Modulated Radiotherapy.
Radiother Oncol
; 100(3): 453-5, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21955664